Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative Chemotherapy vs Chemo-radiotherapy in Gastric Cancer
NCT03601988Phase 3Unknown
- Sponsor
- Huazhong University of Science and Technology
- Start
- Jul 2018
- Primary completion
- Jul 2020
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in gastric cancer (GC) (2 arms), sponsored by Huazhong University of Science and Technology. Primary endpoint: Disease-Free Survival at 36 months. Status: unknown.
02
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT03601988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03601988.